199 related articles for article (PubMed ID: 2571179)
1. Role of dopamine receptors in gastrointestinal motility.
Dhasmana KM; Banerjee AK; Zhu YN; Erdmann W; Parmar SS; Salzman SK
Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179
[TBL] [Abstract][Full Text] [Related]
2. The role of dopamine (D2), alpha and beta-adrenoceptor receptors in the decrease in gastrointestinal transit induced by dopamine and dopamine-related drugs in the rat.
Dhasmana KM; Villalón CM; Zhu YN; Parmar SS
Pharmacol Res; 1993; 27(4):335-47. PubMed ID: 8103596
[TBL] [Abstract][Full Text] [Related]
3. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
4. Positive inotropic effect of apomorphine on guinea pig myocardium is mediated by dopamine DA1 receptors.
Wang N; Zhao DH; Sheng BH
Zhongguo Yao Li Xue Bao; 1991 May; 12(3):207-11. PubMed ID: 1781280
[TBL] [Abstract][Full Text] [Related]
5. Influences of dopamine agonists and antagonists of baclofen antinociception in mice.
Zarrindast MR; Moghaddampour E
Arch Int Pharmacodyn Ther; 1991; 309():42-50. PubMed ID: 1679622
[TBL] [Abstract][Full Text] [Related]
6. The effect of dopamine on rat gastric motility.
Nagahata Y; Urakawa T; Kuroda H; Tomonaga K; Idei H; Kawakita N; Yoshizumi K; Saitoh Y
Gastroenterol Jpn; 1992 Aug; 27(4):482-7. PubMed ID: 1356091
[TBL] [Abstract][Full Text] [Related]
7. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
[TBL] [Abstract][Full Text] [Related]
8. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
9. Apomorphine potentiates vagal bradycardia.
Montastruc P; Damase-Michel C; Montastruc JL
Eur J Pharmacol; 1989 Aug; 166(3):511-4. PubMed ID: 2680522
[TBL] [Abstract][Full Text] [Related]
10. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
11. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of peripheral neuronal dopamine receptors in the rat.
Dupont AG; Lefebvre RA; Bogaert MG
Clin Exp Hypertens A; 1987; 9(5-6):913-29. PubMed ID: 2887314
[TBL] [Abstract][Full Text] [Related]
13. Effect of apomorphine on adrenal medullary catecholamine levels.
Montastruc JL; Gaillard G; Rascol O; Tran MA; Montastruc P
Fundam Clin Pharmacol; 1989; 3(6):665-70. PubMed ID: 2575570
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
Yamawaki S; Lai H; Horita A
J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
Miyazawa T; Matsumoto M; Kato S; Takeuchi K
Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of rectosigmoid motility: action of domperidone.
Wiley J; Owyang C
J Pharmacol Exp Ther; 1987 Aug; 242(2):548-51. PubMed ID: 3612550
[TBL] [Abstract][Full Text] [Related]
18. L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.
Williams M; Martin GE; Remy DC; Hichens M; Mangel AW; Taylor DA; Yarbrough GG; Bendesky RJ; King SW; Robinson JL
J Pharmacol Exp Ther; 1984 Jun; 229(3):775-81. PubMed ID: 6547178
[TBL] [Abstract][Full Text] [Related]
19. Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine.
Goiny M; Uvnäs-Moberg K
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):16-9. PubMed ID: 2888024
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
